These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 19200213)

  • 1. Treatment of infiltrating basal cell carcinoma with the combination of intralesional IFNalpha-2b and topical imiquimod 5% cream.
    Turan A; Saricaoglu H; Baskan EB; Toker SC; Tunali S
    Int J Dermatol; 2009 Feb; 48(2):214-5. PubMed ID: 19200213
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter: Imiquimod 5% cream as adjunctive therapy for primary, solitary, nodular basal cell carcinomas before Mohs micrographic surgery: a randomized, double-blind, vehicle-controlled study.
    Moehrle M; Breuninger H; Schippert W; Häfner HM
    Dermatol Surg; 2010 Mar; 36(3):428-30. PubMed ID: 20402949
    [No Abstract]   [Full Text] [Related]  

  • 3. Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
    Chitwood K; Etzkorn J; Cohen G
    Dermatol Surg; 2013 Sep; 39(9):1306-16. PubMed ID: 23915332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case study: Imiquimod 5% cream in the treatment of a large nodular basal cell carcinoma.
    Shulstad RM
    Dermatol Nurs; 2009; 21(2):86-7. PubMed ID: 19507375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Imiquimod cream. A cream to use with precaution].
    Taeron C
    Rev Infirm; 2010 Jun; (161):47-9. PubMed ID: 20536098
    [No Abstract]   [Full Text] [Related]  

  • 6. Multiple basal cell carcinomas after radiation treatment: successful treatment with topical imiquimod.
    Santiago Sánchez-Mateos D; Goiriz Valdés R; Daudén Tello E
    Clin Exp Dermatol; 2010 Mar; 35(2):199-200. PubMed ID: 19486047
    [No Abstract]   [Full Text] [Related]  

  • 7. Superficial basal cell carcinoma treated with imiquimod 5% topical cream for a 4-week period: a case series.
    Ruiz-Villaverde R; Sánchez-Cano D; Burkhardt-Pérez P
    J Eur Acad Dermatol Venereol; 2009 Jul; 23(7):828-31. PubMed ID: 19646136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topical and light-based treatments for basal cell carcinoma.
    Robinson JK; Hernandez C; Anderson ER; Nickoloff B
    Semin Cutan Med Surg; 2003 Sep; 22(3):171-6. PubMed ID: 14649584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 'Rub on' treatment for basal-cell carcinoma.
    Kerr C
    Lancet Oncol; 2002 Apr; 3(4):201. PubMed ID: 12067676
    [No Abstract]   [Full Text] [Related]  

  • 10. Topical imiquimod treatment for nodular basal cell carcinomas: an open-label series.
    Huber A; Huber JD; Skinner RB; Kuwahara RT; Haque R; Amonette RA
    Dermatol Surg; 2004 Mar; 30(3):429-30. PubMed ID: 15008876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cream to be tested as skin cancer care.
    Expert Rev Anticancer Ther; 2002 Dec; 2(6):621. PubMed ID: 12503207
    [No Abstract]   [Full Text] [Related]  

  • 12. Pilot study using topical imiquimod 5% cream in the treatment of nodular basal cell carcinoma after initial treatment with curettage.
    Neville JA; Williford PM; Jorizzo JL
    J Drugs Dermatol; 2007 Sep; 6(9):910-4. PubMed ID: 17941362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
    Vun Y; Siller G
    Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Residual basal cell carcinoma after treatment with imiquimod: a caution on assuming complete cure.
    Harting M; Vujevich J; Goldberg LH
    Dermatol Surg; 2007 Dec; 33(12):1516-9. PubMed ID: 18076623
    [No Abstract]   [Full Text] [Related]  

  • 15. Topical imiquimod therapy for basal and squamous cell carcinomas: a clinical experience.
    Tillman DK; Carroll MT
    Cutis; 2007 Mar; 79(3):241-8. PubMed ID: 17674590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nonsyndromic multiple basal cell carcinomas successfully treated with imiquimod 5% cream.
    Kocabaş E; Ermertcan AT; Bilaç C; Bilaç DB; Temiz P
    Cutan Ocul Toxicol; 2010 Dec; 29(4):300-2. PubMed ID: 20684662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up.
    Vidal D; Matías-Guiu X; Alomar A
    Arch Dermatol; 2007 Feb; 143(2):266-8. PubMed ID: 17310012
    [No Abstract]   [Full Text] [Related]  

  • 18. 5% imiquimod cream for the treatment of large superficial basal cell carcinoma.
    Shumack S; Gebauer K; Quirk C; Macdonald K; Walters SA; Owens M
    Arch Dermatol; 2004 Oct; 140(10):1286-7. PubMed ID: 15492202
    [No Abstract]   [Full Text] [Related]  

  • 19. Imiquimod and pulmonary embolism: a case report.
    Leroy B; Richez A; Wolf F; Descotes J; Vial T
    Therapie; 2014; 69(2):180-1. PubMed ID: 24926639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Imiquimod, pegylated interferon-alpha-2b and interleukin-2 in the treatment of cutaneous melanoma metastases].
    Loquai C; Nashan D; Metze D; Beiteke U; Rüping KW; Luger TA; Grabbe S
    Hautarzt; 2004 Feb; 55(2):176-81. PubMed ID: 14968329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.